Daniel S. Farb's Schedule 13D Filing for Artelo Biosciences, Inc.

Daniel S. Farb, a Canadian citizen and President of Mill Pond Capital, LLC, filed a Schedule 13D with the SEC regarding his holdings in Artelo Biosciences, Inc. As of September 16, 2025, Farb directly owns 153,000 shares of common stock, representing approximately 9.8% of the outstanding shares. He also holds warrants to purchase additional shares. Farb purchased these securities based on his belief that they were undervalued and represent an attractive investment opportunity. On September 19, 2025, Farb nominated himself and Scott D. Pomfret for election to the company's Board of Directors at the 2025 annual meeting. Farb has engaged in discussions with the company's management and other stockholders regarding potential opportunities to unlock stockholder value, including potential investments and financing transactions. He may continue to take actions such as purchasing additional shares, selling shares, or engaging in discussions with the company's management and Board.